ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionAscent Group, LLC
Latest Disclosed Ownership1,366 shares
Latest Disclosed Value $ 306,640
Ascent Group, LLC reports 40.17% decrease in ownership of RMD / ResMed Inc.

On May 15, 2026 - Ascent Group, LLC filed a 13F-HR form disclosing ownership of 1,366 shares of ResMed Inc. (MX:RMD) valued at $306,640 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 2,283 shares of ResMed Inc.. This represents a change in shares of -40.17% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RESMED COM 761152107 1,366 -917 -40.17 307 -44.26 0.0035
2026-01-20 2025-12-31 13F RESMED COM 761152107 2,283 -9 -0.39 550 -12.44 0.0188
2025-10-20 2025-09-30 13F RESMED COM 761152107 2,292 -455 -16.56 627 -11.44 0.0222
2025-07-21 2025-06-30 13F RESMED COM 761152107 2,747 14 0.51 709 15.88 0.0276
2025-05-16 2025-03-31 13F RESMED COM 761152107 2,733 33 1.22 612 -0.97 0.0263
2025-02-21 2024-12-31 13F RESMED COM 761152107 2,700 -224 -7.66 617 -13.46 0.0464
2024-11-14 2024-09-30 13F RESMED COM 761152107 2,924 48 1.67 714 29.64 0.0541
2024-08-15 2024-06-30 13F RESMED COM 761152107 2,876 207 7.76 551 4.17 0.0448
2024-05-15 2024-03-31 13F RESMED COM 761152107 2,669 -760 -22.16 529 -15.52 0.0466
2024-02-14 2023-12-31 13F RESMED COM 761152107 3,429 339 10.97 626 41.08 0.0594
2023-11-14 2023-09-30 13F RESMED COM 761152107 3,090 -886 -22.28 443 -37.78 0.0489
2023-08-14 2023-06-30 13F RESMED COM 761152107 3,976 549 16.02 713 -5.07 0.0785
2023-05-10 2023-03-31 13F RESMED COM 761152107 3,427 1,465 74.67 750 83.82 0.0799
2023-02-17 2022-12-31 13F RESMED COM 761152107 1,962 -33 -1.65 408 -8.52 0.0481
2022-11-15 2022-09-30 13F RESMED COM 761152107 1,995 45 2.31 446 -4.90 0.0542
2022-08-05 2022-06-30 13F RESMED COM 761152107 1,950 -286 -12.79 469 -13.47 0.0561
2022-05-10 2022-03-31 13F RESMED COM 761152107 2,236 368 19.70 542 23.46 0.0631
2022-03-01 2021-12-31 13F RESMED COM 761152107 1,868 1,868 439 0.0559
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.